Momelotinib, 98%, 100mg
$299.00
In stock
SKU
Q674
Momelotinib / CYT387, an inhibitor of Janus kinases JAK1 and JAK2, is being developed as a drug for myelofibrosis and currently undergoes Phase I/II clinical trials. Additional potential treatment indications for CYT387 include other myeloproliferative neoplasms, cancer (solid and liquid tumors) and inflammatory conditions.
THIS PRODUCT IS NOT FOR HUMAN USE
This Product Is For Research Use Only
Cat#: Q674
Name: Momelotinib free base
CAS#: 1056634-68-4 (free base)
Chemical Formula: C23H22N6O2
Molecular Weight: 414.46
Appearance: Yellow solid powder
Purity: >98%
Delivery within 3-7 Days
For Bulk quantities,
Write Your Own Review